NIH's Collins defends study of oxygen dosing in premature infants

06/6/2013 | National Public Radio

NIH chief Dr. Francis Collins rejected criticism from the Office of Human Research Protections over a study that evaluated dosing of oxygen for premature infants. At the time the study began, data did not indicate outcomes would be worse at either end of the studied spectrum of oxygen dosing, Collins and two other NIH officials write in the New England Journal of Medicine. The controversy "has alarmed some of the parents of infants who were in the study, confused the biomedical research community, and befuddled [Institutional Review Boards]," they wrote.

View Full Article in:

National Public Radio

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD